33 related articles for article (PubMed ID: 22055623)
1. Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Indian Patients with Deep Vein Thrombosis.
Sharma S; Jamwal M; Uppal V; Senee HK; Jindal M; Ahluwalia J; Das R; Varma N; Malhotra P; Kumar N
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):331-334. PubMed ID: 38708166
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women.
Mary MJ; Saravanan L; Deecaraman M; Vijayalakshmi M; Umashankar V; Sailaja J
Bioinformation; 2017; 13(5):149-153. PubMed ID: 28690381
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer.
Haghshenas MR; Shiravani Z; Samare-Najaf M; Khansalar S; Razavinasab SA; Ghaderi A; Jamali N
Eur Cytokine Netw; 2023 Dec; 34(4):63-69. PubMed ID: 38526176
[TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of 49 SNPs Covering 25,446 Cases and 41,106 Controls Identifies Polymorphisms in Hormone Regulation and DNA Repair Genes Associated with Increased Endometrial Cancer Risk.
Das AP; Chaudhary N; Tyagi S; Agarwal SM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981012
[TBL] [Abstract][Full Text] [Related]
5. Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer.
Ronsini C; Mosca L; Iavarone I; Nicoletti R; Vinci D; Carotenuto RM; Pasanisi F; Solazzo MC; De Franciscis P; Torella M; La Verde M; Colacurci N; Cobellis L; Vizzielli G; Restaino S
Front Oncol; 2022; 12():965029. PubMed ID: 36185260
[TBL] [Abstract][Full Text] [Related]
6. Fertility issue in early stage endometrial cancer patients.
Topçu HO; Kaya C; Oral E
Transl Cancer Res; 2020 Dec; 9(12):7797-7808. PubMed ID: 35117382
[TBL] [Abstract][Full Text] [Related]
7. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract][Full Text] [Related]
8. The plasminogen activator inhibitor-1 paradox in cancer: a mechanistic understanding.
Kubala MH; DeClerck YA
Cancer Metastasis Rev; 2019 Sep; 38(3):483-492. PubMed ID: 31734763
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of thrombophilic gene polymorphisms in an azari population of iran.
Bargahi N; Farajzadeh M; Poursadegh-Zonouzi A; Farajzadeh D
Hematol Rep; 2014 Apr; 6(2):5321. PubMed ID: 25013715
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W
PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240
[TBL] [Abstract][Full Text] [Related]
11. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.
Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L
Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
Błasiak J; Smolarz B
Acta Biochim Pol; 2000; 47(1):191-9. PubMed ID: 10961693
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
Ma Z; Paek D; Oh CK
Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
[TBL] [Abstract][Full Text] [Related]
15. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
Gilabert-Estellés J; Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A
Thromb Res; 2012 Aug; 130(2):242-7. PubMed ID: 22055623
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
